Gilead ($GILD) announced Q4 & FY 2025 results on Feb 10, 2026; press release is filed as Exhibit 99.1 to…
Filed with the SEC on · Summarized by InvestorsBot
Gilead ($GILD) announced Q4 & FY 2025 results on Feb 10, 2026; press release is filed as Exhibit 99.1 to the 8‑K — see Exhibit 99.1 for full financial details. 📢📄 #Earnings #SECfilings
Gilead ($GILD) presented both GAAP and non‑GAAP metrics; management uses non‑GAAP for operating/budget planning. Reconciliations of GAAP to non‑GAAP are on pages 11–14 of the press release. ⚖️ #Biotech #Earnings
Gilead ($GILD) notes Item 2.02/9.01 and Exhibit 99.1 are “furnished,” not “filed” under Section 18 — not subject to Section 18 liabilities and not incorporated by reference in other filings. 📝 #SECfilings #Compliance